Which screening strategy should be offered to women with BRCA1 or BRCA2 mutations? A simulation of comparative cost-effectiveness

Systematic Review: Using Magnetic Resonance Imaging to Screen Women at High Risk for Breast Cancer

(2013) Ellen Warner et al.   ANNALS OF INTERNAL MEDICINE

Safety and cost-effectiveness of shortening hospital follow-up after breast cancer treatment

(2012) W. Lu et al.   BRITISH JOURNAL OF SURGERY

Differences in Natural History between Breast Cancers in BRCA1 and BRCA2 Mutation Carriers and Effects of MRI Screening-MRISC, MARIBS, and Canadian Studies Combined

(2012) E. A. M. Heijnsdijk et al.   CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION

Breast Cancer Incidence After Risk-Reducing Salpingo-Oophorectomy in BRCA1 and BRCA2 Mutation Carriers

(2012) I. E. Fakkert et al.   Cancer Prevention Research

Exposure to diagnostic radiation and risk of breast cancer among carriers of BRCA1/2 mutations: retrospective cohort study (GENE-RAD-RISK)

(2012) A. Pijpe et al.   BMJ-British Medical Journal

The evidence base for breast cancer screening

(2011) Paul Glasziou et al.   PREVENTIVE MEDICINE

Penetrance of breast cancer, ovarian cancer and contralateral breast cancer in BRCA1 and BRCA2 families: high cancer incidence at older age

(2010) Dorina M. van der Kolk et al.   BREAST CANCER RESEARCH AND TREATMENT

Exposure to low-dose radiation and the risk of breast cancer among women with a familial or genetic predisposition: a meta-analysis

(2010) Marijke C. Jansen-van der Weide et al.   EUROPEAN RADIOLOGY

Performance of First Mammography Examination in Women Younger Than 40 Years

(2010) Bonnie C. Yankaskas et al.   JNCI-Journal of the National Cancer Institute

The validation of a simulation model incorporating radiation risk for mammography breast cancer screening in women with a hereditary-increased breast cancer risk

(2009) Marcel J.W. Greuter et al.   EUROPEAN JOURNAL OF CANCER